Evidence map›Paper›PMID 30541081›Full record

ArticleILAR journal2018

In Vivo Imaging With Confirmation by Histopathology for Increased Rigor and Reproducibility in Translational Research: A Review of Examples, Options, and Resources.

Kathleen Gabrielson, Robert Maronpot, Sébastien Monette, Coraline Mlynarczyk, Yuval Ramot, Abraham Nyska, Polina Sysa-Shah

Abstract read
In one paragraph

Article in ILAR journal, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Review
  13. NoninvasiveWorld journal of stem cells · 2020
    Review
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Kathleen GabrielsonDepartments of Molecular and Comparative Pathology and Pathology School of Medicine, Environmental Health Engineering Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Maryland.
Robert MaronpotMaronpot Consulting LLC, Raleigh, North Carolina.
Sébastien MonetteLaboratory of Comparative Pathology, Memorial Sloan Kettering Cancer Center, The Rockefeller University, Weill Cornell Medicine, New York, New York.
Coraline MlynarczykDepartment of Medicine, Division of Hematology & Medical Oncology and the Meyer Cancer Center, Weill Cornell Medicine, New York, New York.
Yuval RamotDepartment of Dermatology, Hadassah-Hebrew University Medical Center, Kiryat Hadassah, Jerusalem, Israel.
Abraham NyskaSackler School of Medicine, Tel Aviv University, Tel Aviv, Israel and Toxicologic Pathology, Timrat, Israel.
Polina Sysa-ShahDepartment of Radiology, Miller Research Building Molecular Imaging Service Center, Johns Hopkins University, Baltimore, Maryland.

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Nicholas D Socci · 1985 to 2026
$347.4M
Identification of novel spermine oxidase (SMOX) inhibitors as probes for an emerging chemoprevention targetR01CA204345 · NCI · JOHNS HOPKINS UNIVERSITY · PI CASERO, ROBERT A., WOSTER, PATRICK M · 2016 to 2020
$3.4M
Signal Transduction in the Heart after Cancer TherapyR01HL088649 · NHLBI · JOHNS HOPKINS UNIVERSITY · PI GABRIELSON, KATHLEEN LOUISE · 2008 to 2012
$2.3M
HER2-pretargeting image-guided therapy of breast cancerR01CA209884 · NCI · JOHNS HOPKINS UNIVERSITY · PI ARTEMOV, DMITRI · 2017 to 2021
$2.0M
Evaluation of molecular determinants of racial disparity in triple-negative breast cancerR01CA204555 · NCI · JOHNS HOPKINS UNIVERSITY · PI SHARMA, DIPALI · 2017 to 2021
$1.9M
Imaging cell death in a preclinical rat model with metastatic osteosarcomaR21CA229582 · NCI · JOHNS HOPKINS UNIVERSITY · PI GABRIELSON, KATHLEEN LOUISE · 2018 to 2019
$386k
NCI NIH HHS P30 CA008748NCI NIH HHS R01 CA204345NCI NIH HHS R01 CA204555NCI NIH HHS R01 CA209884NCI NIH HHS R21 CA229582NHLBI NIH HHS R01 HL088649
6 · The paper itself

Abstract

Preclinical noninvasive imaging can be an indispensable tool for studying animal models of disease. In vivo imaging to assess anatomical, functional, and molecular features requires verification by a comparison to the macroscopic and microscopic morphological features, since all noninvasive in vivo imaging methods have much lower resolution than standard histopathology. Comprehensive pathological evaluation of the animal model is underutilized; yet, many institutions have veterinary or human pathologists with necessary comparative pathology expertise. By performing a rigorous comparison to gross or histopathology for image interpretation, these trained individuals can assist scientists with the development of the animal model, experimental design, and evaluation of the in vivo imaging data. These imaging and pathology corroboration studies undoubtedly increase scientific rigor and reproducibility in descriptive and hypothesis-driven research. A review of case examples including ultrasound, nuclear, optical, and MRI is provided to illustrate how a wide range of imaging modalities data can be confirmed by gross or microscopic pathology. This image confirmation and authentication will improve characterization of the model and may contribute to decreasing costs and number of animals used and to more rapid translation from preclinical animal model to the clinic.

Indexed as

AnimalsAnimals, LaboratoryDisease Models, AnimalHumansReproducibility of ResultsTranslational Research, BiomedicalCTgross and histopathologyMRIoptical imagingPET and SPECTpreclinical imagingrigor and reproducibilityultrasound imaging

Identifiers

PMID30541081
PMCPMC6645176

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.